The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge
- Janine L. Ferrant*
- , Christopher D. Benjamin
- , Anne H. Cutler
- , Susan L. Kalled
- , Yen Ming Hsu
- , Ellen A. Garber
- , Donna M. Hess
- , Renee I. Shapiro
- , Norma S. Kenyon
- , David M. Harlan
- , Allan D. Kirk
- , Linda C. Burkly
- , Frederick R. Taylor
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations